Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen

Yale J Biol Med. 1971 Feb-Apr;43(4-5):297-306.
No abstract available

MeSH terms

  • Acetamides / antagonists & inhibitors
  • Acetamides / pharmacology
  • Acetates / antagonists & inhibitors*
  • Amides / antagonists & inhibitors*
  • Animals
  • Body Weight
  • Carcinogens / antagonists & inhibitors*
  • Carcinogens / pharmacology
  • Carcinoma, Hepatocellular / chemically induced*
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / pathology
  • Chloramphenicol / administration & dosage
  • Chloramphenicol / pharmacology*
  • Chloramphenicol / therapeutic use
  • Diet
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Liver Cirrhosis, Experimental / chemically induced
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology
  • Male
  • Models, Biological
  • Neoplasm Metastasis
  • Neoplasms, Experimental / chemically induced
  • Protein Binding / drug effects*
  • Protein Biosynthesis
  • Rats
  • Time Factors

Substances

  • Acetamides
  • Acetates
  • Amides
  • Carcinogens
  • Chloramphenicol